Notice of expansion of CNS sales force of Samil Pharmaceutical, which took over Sandoz products
2023-06-26 02:46:01 As of this month, the withdrawal of permission for major items of Sandoz Korea, which decided to withdraw from the domestic business, has become a reality. As Samil Pharmaceutical decides to take responsibility for the remaining central nervous system (CNS)-oriented items after withdrawal, its presence in the prescription market is expected to grow … Read more